Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $884.17 | 48 | 78.9% |
| Education | $236.01 | 8 | 21.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $455.28 | 19 | $0 (2021) |
| Boston Scientific Corporation | $168.48 | 7 | $0 (2024) |
| BAXTER HEALTHCARE | $76.15 | 2 | $0 (2017) |
| KARL STORZ Endoscopy-America | $62.00 | 1 | $0 (2017) |
| Dendreon Pharmaceuticals LLC | $61.05 | 3 | $0 (2020) |
| Allergan Inc. | $55.41 | 4 | $0 (2019) |
| Janssen Biotech, Inc. | $38.99 | 3 | $0 (2019) |
| AUGMENIX, INC. | $32.34 | 2 | $0 (2017) |
| PFIZER INC. | $30.53 | 2 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $23.87 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $86.44 | 3 | Boston Scientific Corporation ($72.58) |
| 2023 | $19.01 | 1 | Boston Scientific Corporation ($19.01) |
| 2022 | $17.09 | 1 | Boston Scientific Corporation ($17.09) |
| 2021 | $111.45 | 4 | Astellas Pharma US Inc ($99.99) |
| 2020 | $71.48 | 3 | Boston Scientific Corporation ($46.56) |
| 2019 | $304.45 | 15 | Astellas Pharma US Inc ($220.04) |
| 2018 | $245.17 | 16 | Astellas Pharma US Inc ($97.13) |
| 2017 | $265.09 | 13 | BAXTER HEALTHCARE ($76.15) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $13.86 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2024 | Boston Scientific Corporation | LITHOCLAST (Device) | Food and Beverage | In-kind items and services | $57.36 | General |
| Category: EMS Swiss LithoClast Triology_URO | ||||||
| 01/16/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: rezum_URO | ||||||
| 07/26/2023 | Boston Scientific Corporation | GreenLight XPS (Device) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: GreenLight_URO | ||||||
| 02/01/2022 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 11/10/2021 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 04/29/2021 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 03/09/2021 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 01/04/2021 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 11/18/2020 | Boston Scientific Corporation | REZUM (Device) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: PROSTATE HEALTH | ||||||
| 11/17/2020 | Boston Scientific Corporation | REZUM (Device) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: PROSTATE HEALTH | ||||||
| 02/20/2020 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/14/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: HYPERHYDROSIS | ||||||
| 11/14/2019 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: UROLOGY | ||||||
| 10/09/2019 | Boston Scientific Corporation | REZUM (Device) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: PROSTATE HEALTH | ||||||
| 07/31/2019 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: UROLOGY | ||||||
| 07/18/2019 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/10/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $88.00 | General |
| 06/03/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: ONCOLOGY | ||||||
| 04/17/2019 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: UROLOGY | ||||||
| 04/04/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: ONCOLOGY | ||||||
| 03/04/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Oncology | ||||||
| 02/19/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/13/2019 | Astellas Pharma US Inc | VESICARE (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 828 | 1,050 | $209,398 | $59,209 |
| 2022 | 11 | 881 | 1,027 | $180,676 | $56,742 |
| 2021 | 14 | 945 | 1,122 | $174,752 | $64,593 |
| 2020 | 12 | 903 | 1,060 | $148,593 | $47,492 |
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 172 | 250 | $52,794 | $15,198 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 223 | 302 | $43,248 | $11,760 | 27.2% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 20 | 20 | $20,396 | $6,057 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 72 | 95 | $19,915 | $5,766 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 91 | 108 | $15,372 | $5,037 | 32.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 73 | 86 | $17,249 | $4,399 | 25.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 45 | 53 | $10,428 | $2,935 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 28 | 28 | $8,145 | $2,167 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $8,214 | $2,160 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $4,310 | $1,409 | 32.7% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 11 | 11 | $3,564 | $960.70 | 27.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $2,980 | $620.40 | 20.8% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 25 | 28 | $1,776 | $506.52 | 28.5% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 11 | 11 | $1,007 | $233.00 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 186 | 250 | $45,617 | $15,117 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 217 | 252 | $31,101 | $11,001 | 35.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 64 | 64 | $17,438 | $5,109 | 29.3% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 14 | 16 | $15,857 | $4,914 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 61 | 77 | $14,150 | $4,833 | 34.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 76 | 86 | $16,609 | $4,527 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 74 | 86 | $10,521 | $3,630 | 34.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 38 | 38 | $5,776 | $1,418 | 24.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 18 | 18 | $4,890 | $1,281 | 26.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 24 | 24 | $4,614 | $1,164 | 25.2% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 11 | 11 | $3,311 | $870.69 | 26.3% |
About Dr. Gregory Adams, M.D
Dr. Gregory Adams, M.D is a Urology healthcare provider based in Kalispell, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1366659476.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Adams, M.D has received a total of $1,120 in payments from pharmaceutical and medical device companies, with $86.44 received in 2024. These payments were reported across 56 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($884.17).
As a Medicare-enrolled provider, Adams has provided services to 3,557 Medicare beneficiaries, totaling 4,259 services with total Medicare billing of $228,036. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Kalispell, MT
- Active Since 05/17/2007
- Last Updated 01/15/2013
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1366659476
Products in Payments
- XTANDI (Drug) $174.24
- CMOS VIDEO URETEROSCOPE, 8.5 FR. X 675MM (Device) $62.00
- PROVENGE (Drug) $61.05
- REZUM (Device) $59.80
- LITHOCLAST (Device) $57.36
- VESICARE (Drug) $55.01
- Surgical Care - Tisseel (Biological) $44.72
- Erleada (Drug) $38.99
- Myrbetriq (Drug) $38.12
- SpaceOAR (Device) $32.34
- TISSEEL (Biological) $31.43
- BOTOX (Biological) $28.08
- BOTOX THERAPEUTIC (Biological) $27.33
- ELIGARD (Drug) $23.87
- Lupron (Drug) $21.68
- GreenLight XPS (Device) $19.01
- SpaceOAR VUE System - 10mL (Device) $17.09
- SUTENT (Drug) $16.67
- Rezum Generator (Device) $15.22
- MYRBETRIQ (Drug) $13.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Kalispell
Amy Mckerrow, Md, MD
Urology — Payments: $12,896
Jonathan Mercer, Md, MD
Urology — Payments: $6,152
Sarabeth Martin, M.d, M.D
Urology — Payments: $3,202
John Andenoro, Md, MD
Urology — Payments: $2,892
Geraldine Sheu, M.d, M.D
Urology — Payments: $1,854
Vassilis Siomos, M.d, M.D
Urology — Payments: $1,708